Cosmos Health to acquire Docpharm GmbH for €800K cash plus €1M credit line

Cosmos Health Inc.

Purchase price €800,000 in cash to Docpharm owners; additional €1,000,000 credit line for working capital.
Closing subject to due diligence, definitive SPA, board/stockholder approvals, and PCAOB-auditable financials.
Exclusivity through July 15, 2023; Docpharm is an ISO/GDP-certified German pharmaceutical distributor since 1995.
Current managing directors to remain; new service agreements with equal or better economic terms.
Cosmos to bear costs of due diligence and audit as part of the transaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.